Brief: Tanvex Biopharma Says 2023 Net Loss At T$2.14 Bln
14/03/2024 07:10
March 14 (Reuters) - Tanvex Biopharma Inc 6541.TW :
* SAYS 2023 NET LOSS AT T$2.14 BILLION ($67.95 million)
Source text for Eikon: ID:nMOP1nk0kt
Further company coverage: 6541.TW
($1 = 31.4940 Taiwan dollars)
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on Tanvex Biopharma
See all newsBrief: Tanvex Biopharma Announces Merger Plan With Unit Of Bora Pharmaceuticals
Brief: Tanvex Biopharma Says 2023 Net Loss At T$2.14 Bln
Brief: Tanvex Biopharma Says Board Approves Plan To Invest Up To $5 Mln In Taiwan Unit
Brief: Tanvex Biopharma Says 9-Month Net Loss At T$1.62 Bln
Brief: Tanvex Biopharma to issue 25 mln new shares for working capital supplement